Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

Keyphrases

Publications

volume 19, number 7, 2024

Frank C Detterbeck, Marcin Ostrowski, Hans Hoffmann, Ramón Rami-Porta, Ray U Osarogiagbon, Jessica Donnington, Maurizio Infante, Mirella Marino, Edith M Marom, Jun Nakajima, Andrew G Nicholson, Paul van Schil, William D Travis, Ming S Tsao, John G Edwards, Hisao Asamura, null null
The International Association for the Study of Lung Cancer Lung Cancer Staging Project: Proposals for Revision of the Classification of Residual Tumor After Resection for the Forthcoming (Ninth) Edition of the TNM Classification of Lung Cancer. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 19 (7) (2024)
William D Travis, Megan Eisele, Katherine K Nishimura, Rania G Aly, Pietro Bertoglio, Teh-Ying Chou, Frank C Detterbeck, Jessica Donnington, Wentao Fang, Philippe Joubert, Kemp Kernstine, Young Tae Kim, Yolande Lievens, Hui Liu, Gustavo Lyons, Mari Mino-Kenudson, Andrew G Nicholson, Mauro Papotti, Ramon Rami-Porta, Valerie Rusch, Shuji Sakai, Paula Ugalde, Paul Van Schil, Chi-Fu Jeffrey Yang, Vanessa J Cilento, Masaya Yotsukura, Hisao Asamura, null null
The International Association for the Study of Lung Cancer (IASLC) Staging Project for Lung Cancer: Recommendation to Introduce Spread Through Air Spaces as a Histologic Descriptor in the Ninth Edition of the TNM Classification of Lung Cancer. Analysis of 4061 Pathologic Stage I NSCLC. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 19 (7) (2024)
Marco Chiappetta, Carolina Sassorossi, Dania Nachira, Filippo Lococo, Elisa Meacci, Enrico Ruffini, Francesco Guerrera, Paraskevas Lyberis, Vittorio Aprile, Marco Lucchi, Marcello Carlo Ambrogi, Diana Bacchin, Andrea Dell'Amore, Carlotta Marino, Giovannimaria Comacchio, Gabriella Roca, Federico Rea, Stefano Margaritora
Survival Outcome After Surgery in Patients With Thymoma Distant Recurrence. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 19 (7) (2024)
Mi Hee Cho, Jong Ho Cho, Dong Wook Shin
Response to Letter to the Editor. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 19 (7) (2024)
Jacobi B Hines, Robert B Cameron, Alessandra Esposito, Leeseul Kim, Luca Porcu, Antonio Nuccio, Giuseppe Viscardi, Roberto Ferrara, Giulia Veronesi, Patrick M Forde, Janis Taube, Everett Vokes, Christine M Bestvina, James M Dolezal, Matteo Sacco, Marta Monteforte, Tina Cascone, Marina C Garassino, Valter Torri
Evaluation of Major Pathologic Response and Pathologic Complete Response as Surrogate End Points for Survival in Randomized Controlled Trials of Neoadjuvant Immune Checkpoint Blockade in Resectable in NSCLC. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 19 (7) (2024)
Koichi Goto
Rain Leaks Under the Trusted Tree. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 19 (7) (2024)
Sophie M Ernst, Ronald van Marion, Peggy N Atmodimedjo, Evert de Jonge, Ron H J Mathijssen, Marthe S Paats, Peter de Bruijn, Stijn L Koolen, Jan H von der Thüsen, Joachim G J V Aerts, Ron H N van Schaik, Hendrikus J Dubbink, Anne-Marie C Dingemans
Clinical Utility of Circulating Tumor DNA in Patients With Advanced KRAS G12C -Mutated NSCLC Treated With Sotorasib. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 19 (7) (2024)
Ying Cheng, Yun Fan, Yanqiu Zhao, Dingzhi Huang, Xingya Li, Peng Zhang, Mafei Kang, Nong Yang, Diansheng Zhong, Zhen Wang, Yan Yu, Yu Zhang, Jun Zhao, Tai Qin, Chenqi Chen, Shiangjiin Leaw, Wenjuan Zheng, Yong Song, null null
Tislelizumab Plus Platinum and Etoposide Versus Placebo Plus Platinum and Etoposide as First-Line Treatment for Extensive-Stage SCLC (RATIONALE-312): A Multicenter, Double-Blind, Placebo-Controlled, Randomized, Phase 3 Clinical Trial. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 19 (7) (2024)
Jane S Afriyie-Mensah, Mary-Ann Dadzie, Verna D N K Vanderpuye, Benedict Calys-Tagoe, Hafisatu Gbadamosi, Patrick Kafui Akakpo, Kow Entsua-Mensah, Adamu Issaka, Alex A Adjei
Lung Cancer in Ghana. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 19 (7) (2024)
Ying-Li Lin, Guo-Sheng Wang, James Cheng-Chung Wei
Rheumatoid Arthritis and Risk of Lung Cancer. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 19 (7) (2024)
Mi Hee Cho, Jong Ho Cho, Dong Wook Shin
Response to Letter to the Editor. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 19 (7) (2024)
Jae Jeong Yang, Wanqing Wen, Wie Zheng, Xiao-Ou Shu
"Some Thoughts on Lung Cancer Risk Prediction Models for Long-Term Smokers in Asia". Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 19 (7) (2024)
Clémence Basse, Jonathan Khalifa, François Thillays, Cécile Le Pechoux, Jean-Michel Maury, Pierre-Emmanuel Bonte, Alexandre Coutte, Nicolas Pourel, Vincent Bourbonne, Olivier Pradier, Aurélie Belliere, Florence Le Tinier, Mélanie Deberne, Ronan Tanguy, Fabrice Denis, Laetitia Padovani, Audrey Zaccariotto, Thierry Molina, Lara Chalabreysse, Geoffrey Brioude, Bertrand Delatour, Jean-Christophe Faivre, Kim Cao, Philippe Giraud, François-Georges Riet, Sébastien Thureau, Delphine Antoni, Carole Massabeau, Audrey Keller, Emilie Bonnet, Delphine Lerouge, Etienne Martin, Nicolas Girard, Angela Botticella
Recommendations for Post-Operative RadioTherapy After Complete Resection of Thymoma-a French DELPHI Consensus Initiative. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 19 (7) (2024)

volume 19, number 8, 2024

Ben Ponvilawan, Janakiraman Subramanian, Dhruv Bansal
The Number of Chemoimmunotherapy Cycles and Clinical Outcomes in Resectable NSCLC. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 19 (8) (2024)
Gavitt A Woodard, David M Jablons
Shades of Gray: Do Never Smokers Benefit From Lung Cancer Screening Programs? Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 19 (8) (2024)
Nobuteru Kubo
Response to Letter to the Editor. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 19 (8) (2024)
Nanami Kosaka, Yuki Kataoka
Letter Regarding "Clinical Utility of Circulating Tumor DNA in Patients With Advanced KRASG12C-Mutated NSCLC Treated With Sotorasib". Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 19 (8) (2024)
Marco Chiappetta, Carolina Sassorossi, Filippo Lococo, Isabella Sperduti
A Response to the Letter to the Editor: "Prognostic Factors for Survival After Thymoma Distant Recurrence Resection". Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 19 (8) (2024)
Leiyun Shi, Zheng Bao
Accurate Prognostic Factor for Carbon-Ion Radiotherapy in Operable Stage I NSCLC. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 19 (8) (2024)
Robert B Cameron, Jacobi B Hines, Valter Torri, Marina C Garassino
A Response Letter by Cameron et al. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 19 (8) (2024)
Tanel Laisaar, Kaire Innos, Jana Jaal, Kersti Oselin, Bruno Sarana, Tõnu Vanakesa, Kaja-Triin Laisaar
Lung Cancer in Estonia. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 19 (8) (2024)
Shirish M Gadgeel, Delvys Rodríguez-Abreu, Balazs Halmos, Marina C Garassino, Takayasu Kurata, Ying Cheng, Erin Jensen, Mark Shamoun, Kumar Rajagopalan, Luis Paz-Ares
Pembrolizumab Plus Chemotherapy for Metastatic NSCLC With Programmed Cell Death Ligand 1 Tumor Proportion Score Less Than 1%: Pooled Analysis of Outcomes After Five Years of Follow-Up. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 19 (8) (2024)
Steven G Gray, Luciano Mutti, Tomer Meirson
Encouraging Fussy Eaters in EGFR-Mutated Lung Cancer. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 19 (8) (2024)
Mei-Mei Zheng, Yi-Long Wu
"Tumor-free survival" Does Not Outweigh the Adverse Effects of Anti-EGFR Therapy and Chemotherapy in Patients With NSCLC. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 19 (8) (2024)
Maisam Makarem, Pasi A Jänne
"Tumor-Free Survival" Outweighs the Side Effects of Combined Anti-EGF Therapy and Chemotherapy in Patients With NSCLC. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 19 (8) (2024)
Andrea S Wolf, Megan Eisele, Dorothy J Giroux, Ritu Gill, Anna K Nowak, Andrea Bille, David Rice, Robert T Ripley, Isabelle Opitz, Francoise Galateau-Salle, Seiki Hasegawa, Hedy L Kindler, Harvey I Pass, Valerie W Rusch, null null
The International Association for the Study of Lung Cancer Pleural Mesothelioma Staging Project: Expanded Database to Inform Revisions in the Ninth Edition of the TNM Classification of Pleural Mesothelioma. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 19 (8) (2024)
Merve A Türk
Editorial Comment: Validation Study for the N Descriptor of the Newly Proposed 9th Edition of the TNM Staging System Proposed by the International Association for the Study of Lung Cancer. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 19 (8) (2024)
Ashley Horne, Ken Harada, Katherine D Brown, Kevin Lee Min Chua, Fiona McDonald, Gareth Price, Paul Martin Putora, Dominic G Rothwell, Corinne Faivre-Finn
Treatment Response Biomarkers: Working Toward Personalized Radiotherapy for Lung Cancer. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 19 (8) (2024)
James Huang, Ray U Osarogiagbon
Author's Reply. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 19 (8) (2024)
Sophie M Ernst, Jan H von der Thüsen, Hendrikus J Dubbink, Anne-Marie C Dingemans
Letter Regarding "Clinical Utility of Circulating Tumor DNA in Patients With Advanced KRASG12C-Mutated NSCLC Treated With Sotorasib". Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 19 (8) (2024)
Shirish M Gadgeel, Delvys Rodríguez-Abreu, Balazs Halmos, Marina C Garassino, Takayasu Kurata, Ying Cheng, Erin Jensen, Mark Shamoun, Kumar Rajagopalan, Luis Paz-Ares
Pembrolizumab Plus Chemotherapy for Metastatic NSCLC With Programmed Cell Death Ligand 1 Tumor Proportion Score Less Than 1%: Pooled Analysis of Outcomes After Five Years of Follow-Up. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 19 (8) (2024)
Fabiana Perrone, Alessandro Leonetti, Marcello Tiseo, Francesco Facchinetti
Benefit With No Target: Long-Term Outcomes of Chemoimmunotherapy in "PD-L1 Negative" NSCLC. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 19 (8) (2024)
In Ha Kim, Geun Dong Lee, Sehoon Choi, Hyeong Ryul Kim, Yong-Hee Kim, Dong Kwan Kim, Seung-Il Park, Jae Kwang Yun
Validation Study for the N Descriptor of the Newly Proposed Ninth Edition of the TNM Staging System Proposed by the International Association for the Study of Lung Cancer. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 19 (8) (2024)
Yun Cheng, Gejing Zhu
Which Factor Determines the Survival Outcome After Surgery in Patients With Thymoma Distant Recurrence? Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 19 (8) (2024)
Rocco Trisolini
The Devil Is in the Details: A Hidden Obstacle to Implementing the Proposed Revision of the N Descriptors in the Ninth Edition of the TNM Classification for Lung Cancer. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 19 (8) (2024)
Li-Yang Hu, Wei-Tao Zhuang, Mao-Jian Chen, Jun Liao, Dong-Fang Wu, Ya-Xiong Zhang, Lan-Lan Pang, Yi-Hua Huang, Tian-Qin Mao, Meng-Juan Yang, Pei-Jian Peng, Jin-Xia Liang, Liang Chen, Lin-Juan Zeng, Li Zhang, Wen-Feng Fang
EGFR Oncogenic Mutations in NSCLC Impair Macrophage Phagocytosis and Mediate Innate Immune Evasion Through Up-Regulation of CD47. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 19 (8) (2024)
Gerard A Silvestri, Robert P Young, Nichole T Tanner, Peter Mazzone
Screening Low-Risk Individuals for Lung Cancer: The Need May Be Present, but the Evidence of Benefit Is Not. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 19 (8) (2024)
Vivek Shukla, Haitao Wang, Lyuba Varticovski, Songjoon Baek, Ruihong Wang, Xinwei Wu, Frank Echtenkamp, Frank Villa-Hernandez, Katherine P Prothro, Sudheer K Gara, Mary R Zhang, Stephanie Shiffka, Razi Raziuddin, Leonard M Neckers, W Marston Linehan, Haobin Chen, Gordon L Hager, David S Schrump
Genome-Wide Analysis Identifies Nuclear Factor 1C as a Novel Transcription Factor and Potential Therapeutic Target in SCLC. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 19 (8) (2024)

volume 19, number 9, 2024

Hujian Hong, Yijiang He, Yanli Qu
Future Radiation Oncology: The Role of Personalization and Standardization in Stereotactic Body Radiotherapy. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 19 (9) (2024)
Sophie M Ernst, Jan H von der Thüsen, Hendrikus J Dubbink, Anne-Marie C Dingemans
A Response to the Letter to the Editor: Comment on "Clinical Utility of Circulating Tumor DNA in Patients With Advanced KRAS(G12C)-Mutated NSCLC Treated With Sotorasib". Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 19 (9) (2024)
Heidi Andersén, Miia Aro, Riitta Kaarteenaho, Jussi Koivunen, Mikko I Mäyränpää, Eero Sihvo, Tuula Vasankari
Lung Cancer in Finland. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 19 (9) (2024)
Yuxin Niu, Jiayue Xie, Zhiyong Li
The Value of Incidental Imaging for Early-Stage Lung Cancer in a High-Risk Non-Screening Cohort: Some Additional Considerations? Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 19 (9) (2024)
Ryoko I Higashiyama, Tatsuya Yoshida
A Response to the Letter to the Editor: Safety Implications of Switching Pembrolizumab Dosage From 200 mg Every 3 Weeks to 400 mg Every 6 Weeks in Patients With Advanced NSCLC. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 19 (9) (2024)
Ching-Yao Yang, Meng-Rui Lee, Pan-Chyr Yang
Beyond Low-Dose Computed Tomography: Emerging Diagnostic Tools for Early Lung Cancer Detection. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 19 (9) (2024)
Zelu Han, Lingshuang Liu, Yi Jiang
Suggestions for the predictive factors related to irAES and research methods during dose switching of pembrolizumab treatment in patients with advanced NSCLC. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 19 (9) (2024)
Luca Roma, Lukas Bubendorf
Suggestions for Improving the Comprehensive Characterization of Lung Pleomorphic Carcinoma. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 19 (9) (2024)
Antonin Levy, Sonja Adebahr, Coen Hurkmans, Catherine Fortpied, Cécile Le Pechoux, Corinne Faivre-Finn, Ursula Nestle
A Response to the Letter to the Editor: The Role of Personalization and Standardization in Stereotactic Body Radiation Therapy. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 19 (9) (2024)
Stephanie Tuminello, Shubham Gulati, Tara Ivic-Pavlicic, Raja Flores, Emanuela Taioli
Response to: "The Value of Incidental Imaging for Early Stage Lung Cancer in High-Risk Nonscreening Cohort: Some Additional Considerations?" Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 19 (9) (2024)
Yanfang Jiang, Lei Zhang
Comment on "Clinical Utility of Circulating Tumor DNA in Patients With Advanced KRAS(G12C)-Mutated NSCLC Treated With Sotorasib". Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 19 (9) (2024)
Lianwei Zhou, Manling Li, Wenbo Li
Suggestions for Improving the Comprehensive Characterization of Lung Pleomorphic Carcinoma. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 19 (9) (2024)